US Broker Ratings

Glaukos Corporation (GKOS) Stock Analysis: Exploring the 19.92% Upside Potential in the Burgeoning Medical Devices Sector

Glaukos Corporation (NYSE: GKOS) is capturing attention in the healthcare sector, specifically within the medical devices industry, thanks to its innovative solutions for ophthalmic conditions and..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating a Volatile 52-Week Range with Strategic Insights

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based healthcare entity specializing in Traditional Chinese Medicine (TCM), presents a unique proposition within the drug manufacturing sector...

HealthEquity, Inc. (HQY) Stock Analysis: A Compelling 28.86% Upside Potential Beckons Investors

HealthEquity, Inc. (NASDAQ: HQY) stands as a formidable player in the health information services industry, offering a technology-enabled services platform that caters to both consumers and..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Powerhouse with a 63.91% Potential Upside

In the dynamic world of biotechnology, Vaxcyte, Inc. (NASDAQ: PCVX) stands out as a robust contender, capturing the attention of investors with its promising product pipeline..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Healthcare Sector With a $17.2 Billion Market Cap

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, particularly in diagnostics and research, continues to capture investor interest with its expansive market cap..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Navigating a 68% Potential Upside in the Biotech Arena

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Axsome Therapeutics, Inc. (NASDAQ: AXSM), a dynamic player in the biotechnology..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 63% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 63.01%. This digital health..

Cencora, Inc. (COR) Stock Analysis: Exploring a 14% Potential Upside

Cencora, Inc. (COR), a titan in the healthcare sector, continues to attract investor attention with its robust market presence and promising financial prospects. As a key..

Inspire Medical Systems, Inc. (INSP): Stock Analysis Unveils Growth Potential Amidst Financial Challenges

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in innovative medical devices targeting obstructive sleep apnea (OSA). Headquartered in Golden..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 21.21% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pioneering force in the biotechnology sector, is capturing investor attention as it navigates the volatile waters of the healthcare industry...

Sanofi (SNY) Stock Analysis: Unveiling a 33.79% Potential Upside in the Healthcare Sector

Sanofi (NASDAQ: SNY), a titan in the healthcare sector and a prominent player in the global drug manufacturing industry, offers a compelling case for investors seeking..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating the Biotech Sector with Stability and Strategic Focus

Nuvalent, Inc. (NASDAQ: NUVL) stands as a noteworthy player in the biotechnology sector, engaging investors with its strategic focus on pioneering cancer therapies. With a market..

Penumbra, Inc. (PEN) Stock Analysis: Exploring a 13% Upside Potential in the Medical Device Sector

As the medical device sector continues to experience robust growth, Penumbra, Inc. (NYSE: PEN) stands out as a key player with a market capitalization of $12.58..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 35.20% Upside Potential and Robust Buy Ratings

For investors seeking opportunities in the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents an intriguing proposition. With a market capitalization of $10.02 billion, this U.S.-based..

Ascendis Pharma A/S (ASND) Stock Analysis: A Promising 33.84% Upside in the Biotech Sphere

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of the biopharmaceutical investment community, bolstered by its innovative TransCon technology and a robust product pipeline aimed..

AstraZeneca PLC (AZN): Analyst Consensus Signals Nearly 30% Upside Potential

As a titan in the biopharmaceutical industry, AstraZeneca PLC (AZN) continues to demonstrate its prowess in drug development and commercialization. Headquartered in Cambridge, United Kingdom, this..

ICON plc (ICLR) Investor Outlook: Assessing a 13% Upside Potential Amidst Robust Analyst Ratings

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector specializing in diagnostics and research, has garnered significant attention from investors due to its strategic..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring a 19% Upside Potential

Novo Nordisk A/S (NVO), a prominent player in the healthcare sector, is capturing investor attention with its substantial market presence and promising growth prospects. With a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating a 35.68% Potential Upside in the Biotech Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a dynamic player in the biotechnology sector, is capturing investor attention with its ambitious pipeline and promising analyst ratings. The UK-based..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating a 11.14% Potential Upside Amid Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a robust market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds